Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jonathan, Yau"'
Autor:
Chih-Jian, Lih, Robin D, Harrington, David J, Sims, Kneshay N, Harper, Courtney H, Bouk, Vivekananda, Datta, Jonathan, Yau, Rajesh R, Singh, Mark J, Routbort, Rajyalakshmi, Luthra, Keyur P, Patel, Geeta S, Mantha, Savitri, Krishnamurthy, Karyn, Ronski, Zenta, Walther, Karin E, Finberg, Sandra, Canosa, Hayley, Robinson, Amelia, Raymond, Long P, Le, Lisa M, McShane, Eric C, Polley, Barbara A, Conley, James H, Doroshow, A John, Iafrate, Jeffrey L, Sklar, Stanley R, Hamilton, P Mickey, Williams
Publikováno v:
The Journal of molecular diagnostics : JMD. 19(2)
The National Cancer Institute-Molecular Analysis for Therapy Choice (NCI-MATCH) trial is a national signal-finding precision medicine study that relies on genomic assays to screen and enroll patients with relapsed or refractory cancer after standard
Autor:
Sara Taylor, Jonathan Yau
Publikováno v:
Laboratory Medicine. 41:517-521
Patient: A 58-year-old Caucasian female Chief Complaint: Altered mental status, fever. Also complains of occipital headache and neck pain. History of Present Illness: Patient had presented to the emergency department 11 days previously with intermitt
Autor:
Alexey V. Sorokin, Poul H. Sorensen, Valentina Evdokimova, Maxim A. Skabkin, Christina Richard, Sergey Guryanov, Jonathan Yau, Lev P. Ovchinnikov, John Th'ng, Anastasia Selyutina, Igor V. Nazimov
Publikováno v:
The EMBO Journal. 24:3602-3612
YB-1 is a DNA/RNA-binding nucleocytoplasmic shuttling protein whose regulatory effect on many DNA- and RNA-dependent events is determined by its localization in the cell. Distribution of YB-1 between the nucleus and the cytoplasm is known to be depen
Autor:
David J. Stewart, M. Christine Cripps, Rakesh Goel, Simone Dahrouge, Jonathan Yau, Eva Tomiak, Susan Huan, Kathy Soltys, Ann Prosser, Ross A. Davies
Publikováno v:
Cancer Chemotherapy and Pharmacology. 41:1-8
We studied the toxicity and efficacy of adding to epirubicin five resistance modulators in the treatment of resistant solid tumors. Additional drugs were added in successive cohorts of patients, such that cohort 1 patients received two drugs along wi
A promising approach for cancer gene therapy is the combination of adenovirus vectors (AdV) with the suicide gene cytosine deaminase and uracil phosphoribosyl transferase (CDColon, two colonsUPRT). While such vectors have been tested in tumor cell li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32c6f3caa4d7eb4e7116b3b5f2fcebd3
https://nrc-publications.canada.ca/eng/view/object/?id=130b1eef-5cff-4456-a43f-391c1e2557ba
https://nrc-publications.canada.ca/eng/view/object/?id=130b1eef-5cff-4456-a43f-391c1e2557ba
Publikováno v:
Clinicalexperimental metastasis. 23(5-6)
Numerous cancer patients fail standard chemotherapy or develop resistance to chemotherapy during the course of treatment. The purpose of this study is to elucidate the overall response of cells obtained from cancer patients and from normal individual
Publikováno v:
Analytical biochemistry. 332(2)
When cells are treated with cytotoxic agents, they enter apoptosis asynchronously to yield cells at various stages of cellular deterioration. This mixture makes it difficult to study the biochemical pathways leading to cell death. We have fractionate